Verastem (VSTM) Profit After Tax (2011 - 2026)
Verastem (VSTM) recorded quarterly Profit After Tax of -$36.6 million in Q1 2026, down 11.16% quarter-over-quarter from -$32.9 million in Q4 2025, and up 29.77% on a YoY basis from -$28.2 million in Q1 2025.
Verastem (VSTM) Profit After Tax (2011 - 2026) Analysis & Trends
Verastem's Profit After Tax history runs 16 years deep, the most recent figure standing at -$36.6 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 29.77% year-over-year to -$36.6 million; the TTM figure through Mar 2026 stood at -$194.0 million (down 30.28% YoY), while the FY2025 annual figure was -$209.5 million, down 60.35% from the prior year.
- Profit After Tax was -$36.6 million for Q1 2026 at Verastem, down from -$32.9 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$8.3 million in Q2 2024 to a low of -$98.5 million in Q3 2025.
- Historically, Profit After Tax has averaged -$31.6 million across 5 years, with a median of -$24.3 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax soared 66.0% in 2024, then sank 311.06% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$16.8 million in 2022, then slumped by 62.83% to -$27.4 million in 2023, then slumped by 135.86% to -$64.6 million in 2024, then jumped by 49.01% to -$32.9 million in 2025, then dropped by 11.16% to -$36.6 million in 2026.
- The last three Profit After Tax figures came in at -$36.6 million (Q1 2026), -$32.9 million (Q4 2025), and -$98.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -36.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.59 Mn |
| Dec 31, 2025 | -32.92 Mn |
| Sep 30, 2025 | -98.52 Mn |
| Jun 30, 2025 | -25.93 Mn |
| Mar 31, 2025 | -52.10 Mn |
| Dec 31, 2024 | -64.55 Mn |
| Sep 30, 2024 | -23.97 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -33.86 Mn |
| Dec 31, 2023 | -27.37 Mn |
| Sep 30, 2023 | -20.00 Mn |
| Jun 30, 2023 | -24.28 Mn |
| Mar 31, 2023 | -15.71 Mn |
| Dec 31, 2022 | -16.81 Mn |
| Sep 30, 2022 | -18.09 Mn |
| Jun 30, 2022 | -21.95 Mn |
| Mar 31, 2022 | -16.96 Mn |
| Dec 31, 2021 | -16.48 Mn |
| Sep 30, 2021 | -22.79 Mn |
| Jun 30, 2021 | -16.90 Mn |